Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A sure bet, time and time and time again: Buy AVEO in the .60's
Guess we'll see tomorrow.
Break? LOL. It annihilated the 50! Monday could be the day the NASDAQ compliance 10 day clock restarts. Regaining compliance and having Bailey publicly state that a R/S is no longer a consideration will be like taking a flamethrower bear hunting.
Is someone fidgeting in here? LOL. I smell burnt cotton
Margin call? LOL
Harry's short position is smelling a little off today.
No Harry on up days. LOL.
Watch. I've said all along, let's talk at Christmas. You say BK, I say twofittay
AVEO support strong at .65
They will file the Tivozanib NDA with the FDA in Q4 '19 after mature O/S data reads out. EUSA will opt-in with the $20M milestone at that time. The FDA will follow suit with the EMA and approve the drug before the 2020 election. Ficla will be in Phase 3 by then and AVEO will have a new partners for AV380 & AV353. The glass is half full.
Aside from Anthony Evnin back in November, AVEO insiders have purchased millions and millions of shares. Who does that with a junk stock?
http://insiderbuyingselling.com/?t=aveo&submit=
Alectinib. Ever hear of it? Tivozanib does for RCC patients what Alectinib does for NSCLC patients with the ALK marker. Chemo and radiation are poisons and are becoming yesterday's news.
Look who's back at the NEA non-whale to help guide the companies they're backing. Just the most recent commissioner of the FDA.
Think .70's, or as one dubious poster keeps saying, .25, is really in the cards here toward Q4?
https://www.fiercebiotech.com/biotech/was-fast-ex-fda-commish-goes-back-to-biotech-investing
https://www.nasdaq.com/symbol/aveo/recommendations
Nasdaq paints a different picture
Working overtime. LOL. This is a fantastic entry point with 20% downside risk and over 400% upside. It happened 2 years ago with the EMA and it will happen again.
Another bogus promotion like this from one of the RCC treatment gurus? https://www.ascopost.com/videos/2019-genitourinary-cancers-symposium/brian-rini-on-the-tivo3-trial-on-tivozanib-vs-sorafenib/
Yes, companies always pay for the opportunity to present at conferences that they have abysmally failed with their drug and will be going bankrupt.
NEA is a venture capital outfit, not a hedge fund. Another lie.
"Testing not done properly?" A lie.
Here you go Harry. This guy knows a little something about renal cell carcinoma. https://vimeo.com/319964000
Desperate claims about the best RCC drug out there.
Institutions like Vanguard, Morgan Stanley, NEA Mgt, Barclays,and TIA CREF believe otherwise. I love refuting these BS statements...it's too easy
No split coming. That is a lie. They are setting it up if needed. It's called "discretionary" in the proxy. Same was done in May '17 without a R/S
Looks like everyone's buying it to me: https://fintel.io/so/us/aveo
The lawsuits' venues were successfully changed to Boston per AVEO's request. Those firms are chasing different ambulances now. We will not a hear another thing about them.
Harry, your assertions mean nothing. Follow the billionaires, not message board trolls posting nonsense.
Another stupid European country approves tivozanib for first line RCC treatment. They must not have heard that there is no science behind the drug that the EMA approved.
Nope, wrong again HC. They did the same proxy in May of 2017. Remember what followed that one? LOL.
Seems like they would have sold at $3 - $4 to make your twisted argument work. Why wouldn't they have taken their 300-400% profits Harry instead of holding? You're a stooge. They have to file Form 4's within 3 days of any trades, and there's been NOT ONE sale filed since they established their stake years ago.
Hey Harry, is David Mott not a whale in your book? He is worth $2B and loves AVEO. Why would a guy worth $2B be scooping AVEO for the past 2 years? Just scroll down to "Complete History of Mr. Mott's Stock"
https://wallmine.com/people/384/david-m-mott
And a big connection with Astra Zeneca....hmmm
Tivozanib works. The trial's endpoint was met. The O/S data will be positive once MATURE, unlike your analysis. Prior mgt screwed the pooch with the FDA. This is a classic comeback story. Micocap pharmas dilute, get over it. They have 5 drugs in pipeline, 3 of which are progressing positively in trials and 1 of which is already being marketed in Europe. Your short position was done at 1.75 to .50 Why did you not cover at .50? Pigs get slaughtered.
oh, so they're buying now so they can dump at .25 Harry? You send a lot of mixed messages, you know it?
Clay the Vulcan shows up and we're down 8%. I hate that MF'er. Harry, did you give Clay a back rub last night?
40M shares. I say NEA qualifies as a whale in a microcap this small.
https://fintel.io/so/us/aveo Going to .25 Harry? Yep, I'm sure your trash talkin is more astute than 40M shares of confidence.
HC or DB? You make the call.
Harry's on the losing end of an AVEO tear from .50 Burnt toast.
:No FDA approval in the US and no chance of approval." Just wondering why you are trying so hard to mislead. Take a lot of Ambien at night Harry?
FDA suggested waiting for mature data before an NDA submission. If they weren't on AVEO's side this time around(or worse yet,if they weren't positive on the science),they would have told them to submit and then promptly issue a CRL. Am I the rookie or are you just making stuff up?
the new offering is $1.15 and NEA just paid $1.25 You continually lie, day after day. Do you work at the White House?